SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid Tumors

Clinical trial NCT07646626 · RECRUITING

Trial details

NCT number: NCT07646626
Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced (Unresectable) or Metastatic Solid Tumors

Start date: 2026-07-17
Primary completion: 2027-06-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.